Paper of the Month

For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2.

For January 2021, we have selected: M. Obermann et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol 2020, November 24, 2020. https://doi.org/10.1016/S1474-4422(20)30363-X.

For December 2020, we have selected the following two papers: Zhang Q et al. ''COVID-19 case fatality and Parkinson’s disease'' and Bsteh G, et al. ''Multiple sclerosis and COVID-19: how many are at risk?''

For December 2020, we have selected the following paper: Deuschl et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017

For November 2020, we have selected: Agarwal P. et al. Neurological manifestations in 404 COVID‑19 patients in Washington State. J Neurol 2020 Aug 6;1-3. doi: 10.1007/s00415-020-10087-z. Online ahead of print.

For November 2020, we have selected: Wang Z. et al. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol 2020;e203311. doi: 10.1001/jamaneurol.2020.3311. Online ahead of print.

For October 2020, we have selected the following Covid-19 paper: Hernández-Fernández F. et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain 2020 Jul 9;awaa239. doi: 10.1093/brain/awaa239. Online ahead of print.

For October 2020, we have selected the following Research paper: Livingston G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

For September 2020, we have selected: The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.

For September 2020, we have selected two complementary papers.

For August 2020, we have selected Turner R.S. et al. “Nilotinib Effects on Safety, Tolerability,and Biomarkers in Alzheimer’s Disease” Annals of Neurology 2020;88:183–194. doi: 10.1002/ana.25775. Epub 2020 May 28.

For August 2020, we have selected Rogers J.P. et al. “Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic” Lancet Psychiatry 2020; 7:611-627.

For July 2020, we have selected: Yang P. et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke

For June 2020, we have selected: Mao L. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China JAMA

For May 2020, we have selected: Lechien JR, Chiesa-Estomba CM, De Siati DR et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild‑to‑moderate forms of the coronavirus disease (COVID‑19): a multicenter European study.